156 related articles for article (PubMed ID: 31702071)
1. Analytical methodologies for the enantiodetermination of citalopram and its metabolites.
Budău M; Hancu G; Rusu A; Muntean DL
Chirality; 2020 Jan; 32(1):32-41. PubMed ID: 31702071
[TBL] [Abstract][Full Text] [Related]
2. Analytical procedures for the determination of the selective serotonin reuptake inhibitor antidepressant citalopram and its metabolites.
Unceta N; Goicolea MA; Barrio RJ
Biomed Chromatogr; 2011 Jan; 25(1-2):238-57. PubMed ID: 21058412
[TBL] [Abstract][Full Text] [Related]
3. Stereospecific determination of citalopram and desmethylcitalopram by capillary electrophoresis and liquid-phase microextraction.
Andersen S; Halvorsen TG; Pedersen-Bjergaard S; Rasmussen KE; Tanum L; Refsum H
J Pharm Biomed Anal; 2003 Sep; 33(2):263-73. PubMed ID: 12972091
[TBL] [Abstract][Full Text] [Related]
4. Determination of the enantiomers of citalopram, its demethylated and propionic acid metabolites in human plasma by chiral HPLC.
Rochat B; Amey M; Van Gelderen H; Testa B; Baumann P
Chirality; 1995; 7(6):389-95. PubMed ID: 7577348
[TBL] [Abstract][Full Text] [Related]
5. Analytical methodologies for the stereoselective determination of fluoxetine: An overview.
Hancu G; Cârcu-Dobrin M; Budău M; Rusu A
Biomed Chromatogr; 2018 Jan; 32(1):. PubMed ID: 28670837
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of citalopram--dose-dependent variation in R- and S-enantiomer ratios.
Tanum L; Strand LP; Refsum H
Pharmacopsychiatry; 2010 Jul; 43(5):190-3. PubMed ID: 20503148
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective HPLC-assay for citalopram and its metabolites.
Zheng Z; Jamour M; Klotz U
Ther Drug Monit; 2000 Apr; 22(2):219-24. PubMed ID: 10774637
[TBL] [Abstract][Full Text] [Related]
8. Enantioselective analysis of citalopram and demethylcitalopram in human whole blood by chiral LC-MS/MS and application in forensic cases.
Johansen SS
Drug Test Anal; 2017 Oct; 9(10):1549-1554. PubMed ID: 28178765
[TBL] [Abstract][Full Text] [Related]
9. Enantiomeric screening of racemic citalopram and metabolites in human urine by entangled polymer solution capillary electrophoresis: an innovatory robustness/ruggedness study.
Berzas-Nevado JJ; Villaseñor-Llerena MJ; Guiberteau-Cabanillas C; Rodríguez-Robledo V
Electrophoresis; 2006 Feb; 27(4):905-17. PubMed ID: 16470634
[TBL] [Abstract][Full Text] [Related]
10. Analysis of enantiomers of citalopram and its demethylated metabolites in plasma of depressive patients using chiral reverse-phase liquid chromatography.
Rochat B; Amey M; Baumann P
Ther Drug Monit; 1995 Jun; 17(3):273-9. PubMed ID: 7624924
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography.
Kosel M; Eap CB; Amey M; Baumann P
J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):234-8. PubMed ID: 9869386
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a liquid chromatographic method for determination of enantiomeric purity of citalopram in bulk drugs and pharmaceuticals.
Nageswara Rao R; Narasa Raju A; Nagaraju D
J Pharm Biomed Anal; 2006 Apr; 41(1):280-5. PubMed ID: 16321492
[TBL] [Abstract][Full Text] [Related]
13. Enantioselective analysis of venlafaxine and its active metabolites: A review on the separation methodologies.
Hancu G; Lupu D; Milan A; Budău M; Barabás-Hajdu E
Biomed Chromatogr; 2021 Jan; 35(1):e4874. PubMed ID: 32367587
[TBL] [Abstract][Full Text] [Related]
14. Enantioselective LC analysis and determination of selective serotonin reuptake inhibitors.
Sethi S; Bhushan R
Biomed Chromatogr; 2020 Jan; 34(1):e4730. PubMed ID: 31652353
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic consequences of a citalopram treatment discontinuation.
Voirol P; Rubin C; Bryois C; Kosel M; Buclin T; Baumann P
Ther Drug Monit; 1999 Jun; 21(3):263-6. PubMed ID: 10365634
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in rats.
Wikell C; Apelqvist G; Carlsson B; Hjorth S; Bergqvist PB; Kugelberg FC; Ahlner J; Bengtsson F
Clin Neuropharmacol; 1999; 22(6):327-36. PubMed ID: 10626092
[TBL] [Abstract][Full Text] [Related]
17. Determination of citalopram in fish brain tissue: benefits of coupling laser diode thermal desorption with low- and high-resolution mass spectrometry.
Borik A; Staňová AV; Brooks BW; Grabicová K; Randák T; Grabic R
Anal Bioanal Chem; 2020 Jul; 412(18):4353-4361. PubMed ID: 32372276
[TBL] [Abstract][Full Text] [Related]
18. Enantioseparation of citalopram enantiomers by capillary electrophoresis: Method development through experimental design and computational modeling.
Budău M; Hancu G; Muntean DL; Papp LA; Cârje AG; Garaj V
Chirality; 2020 Aug; 32(8):1119-1128. PubMed ID: 32506601
[TBL] [Abstract][Full Text] [Related]
19. Enantiomeric determination, validation and robustness studies of racemic citalopram in pharmaceutical formulations by capillary electrophoresis.
Berzas Nevado JJ; Guiberteau Cabanillas C; Villaseñor Llerena MJ; Rodríguez Robledo V
J Chromatogr A; 2005 Apr; 1072(2):249-57. PubMed ID: 15887495
[TBL] [Abstract][Full Text] [Related]
20. Development of a stir bar sorptive extraction based HPLC-FLD method for the quantification of serotonin reuptake inhibitors in plasma, urine and brain tissue samples.
Unceta N; Ugarte A; Sánchez A; Gómez-Caballero A; Goicolea MA; Barrio RJ
J Pharm Biomed Anal; 2010 Jan; 51(1):178-85. PubMed ID: 19660886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
